Is resistance to Dolutegravirpossible when this drug is used in first-line therapy?. Actualizaciones en Sida e Infectología, [S. l.], v. 22, n. 85, 2023. DOI: 10.52226/revista.v22i85.264. Disponível em: https://revista.infectologia.info/index.php/revista/article/view/264. Acesso em: 7 feb. 2026.